Folate and carcinogenesis: Evidence, mechanisms, and implications

Journal of Nutritional Biochemistry

Volumn 10, Issue 2, 1999, Pages 66-88

  Kim, Young In ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Carcinogenesis; Cervical cancer; Chemoprevention; Colon cancer; Folate

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; DNA; FLUOROURACIL; FOLIC ACID; FOLIC ACID ANTAGONIST; METHOTREXATE; ORAL CONTRACEPTIVE AGENT; SALAZOSULFAPYRIDINE;

ADENOMATOUS POLYP; BREAST CANCER; BRONCHUS DISEASE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL DIVISION; CLINICAL TRIAL; COLON MUCOSA; DIET SUPPLEMENTATION; DIETARY INTAKE; DNA METHYLATION; DNA POLYMORPHISM; DNA REPLICATION; ERYTHROBLAST; ESOPHAGUS CANCER; FOLATE METABOLISM; FOLIC ACID BLOOD LEVEL; GENE MUTATION; HUMAN; LIVER CANCER; LUNG CARCINOMA; MALIGNANT TRANSFORMATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PANCREAS CANCER; REVIEW; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; ULCERATIVE COLITIS; UTERINE CERVIX CANCER;

BRONCHUS;

EID: 0033007272     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(98)00074-6     Document Type: Review

References (230)

1. Rim E.B., Willet W.C., Hu F.B., Sampson L., Colditz G.A., Manson J.E., Hennekens C., Stampfer M.J. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA. 279:1998;359-364.
2. Morrison H.I., Schaubel D., Desmeules M., Wigle D.T. Serum folate and a risk of fatal coronary heart disease. JAMA. 275:1996;1893-1896.
3. Nygard O., Vollset S.M., Refsum H., Stensvold I., Tverdal A., Nordrehaug J.E., Ueland P.M., Kvale G. Total plasma homocysteine and cardiovascular risk profile. JAMA. 274:1995;1526-1533.
4. Stampfer M.J., Malinow M.R., Willett W.C., Newcomber L.M., Upson B., Ullmann D., Tishler P.V., Hennekens C.H. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 268:1992;877-881.
5. Wald N., Sneddon J., Densem J., Frost C., Stone R. Prevention of neural tube defects Results of the Medical Research Council Vitamin Study . Lancet. 338:1991;131-137.
6. Czeizel A.E., Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327:1992;1832-1835.
7. Werler M.W., Shapiro S., Mitchell A.A. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA. 269:1993;1257-1261.
8. Mason J.B., Levesque T. Folate Effects on carcinogenesis and the potential for cancer chemoprevention . Oncology. 10:1996;1727-1743.
9. Jennings E. Folic acid as a cancer-preventing agent. Med Hypotheses. 45:1995;297-303.
10. Kim Y.I., Mason J.B. Folate, epithelial dysplasia and colon cancer. Proc. Assoc. Am. Phys. 107:1995;218-227.
11. Glynn S.A., Albanes D. Folate and cancer A review of the literature . Nutr. Cancer. 22:1994;101-119.
12. Mason J.B. Folate and colonic carcinogenesis Searching for a mechanistic understanding . J. Nutr. Biochem. 5:1994;170-175.
13. Massey B., Rubin C. The stomach in pernicious anemia A cytologic study . Am. J. Med. Sci. 227:1954;481-492.
14. Van Niekerk W.A. Cervical cells in megaloblastic anemia of the puerperium. Lancet. 1:1962;1277-1279.
15. Rubin C. Newer advances in the exfoliative cytology of the gastrointestinal tract. Ann. N.Y. Acad. Sci. 63:1956;1377-1398.
16. Wagner C. Biochemical role of folate in cellular metabolism. Bailey L.B. Folate in Health and Disease. 1995;23-42 Marcel Dekker, New York, NY, USA.
17. Kamen B. Folate and antifolate pharmacology. Semin. Oncol. 24:(suppl 18):1997;S18-30-S18-39.
18. Bertino J.R. Biomodulation of 5-fluorouracil with antifolates. Semin. Oncol. 24:(suppl 18):1997;S18-52-S18-56.
19. Farber S. Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer. Blood. 4:1949;160-167.
20. Rosen F., Nichol C.A. Inhibition of the growth of an amethopterin-refractory tumor by dietary restriction of folic acid. Cancer Res. 22:1962;495-500.
21. Little P.A., Sampath A., Paganelli V., et al. The effect of folic acid and its antagonists on Rous chicken sarcoma. Trans. N.Y. Acad. Sci. Series II. 10:1948;91-98.
22. Bills N.D., Hinrichs S.H., Morgan R., Clifford A.J. Delayed tumor onset in transgenic mice fed a low-folate diet. J. Natl. Cancer Inst. 84:1992;332-337.
23. Heimburger D. Localized deficiencies of folic acid in aerodigestive tissues. Ann. N.Y. Acad. Sci. 669:1992;87-96.
24. Witter F.R., Blake D.A., Baumgardner R., Mellitis E.D., Niebyl J.R. Folate, carotene and smoking. Am. J. Obstet. Gynecol. 144:1982;857.
25. Nakazawa Y., Chiba K., Imatoh N., Korotii T., Sakamoto T., Ishizaki T. Serum folic acid levels and antipyrine clearance rates in smokers and non-smokers. Drug Alcohol Depend. 11:1983;201-207.
26. Chen A.T.L., Reidy J.A., Annest J.L., Welty T.K., Zhou H.-G. Increased chromosome fragility as a consequence of blood folate levels, smoking status, and coffee consumption. Environ. Mol. Mutagen. 13:1989;319-324.
27. Ortega R.M., Lopez-Sobaler A.M., Gonzalez-Gross M.M., Redondo R.M., Marzana I., Zamora M.J., Andres P. Influence of smoking on folate intake and blood folate concentrations in a group of elderly Spanish men. J. Am. Coll. Nutr. 13:1994;68-72.
28. Heimburger D.C., Krumdieck C.L., Alexander C.B., Birch R., Dill S.R., Bailey W.C. Localized folic acid deficiency and bronchial metaplasia in smokers Hypothesis and preliminary report . Nutr. Int. 3:1987;54-60.
29. Piyathilake C.J., Hine R.J., Dasanayake A.P., Richards E.W., Freeberg L.E., Vaughn W.H., Krumdieck C.L. Effect of smoking on folate levels in buccal mucosal cells. Int. J. Cancer. 52:1992;566-569.
30. Piyathilake C.J., Macaluso M., Hine R.J., Richards E.W., Krumdieck C.L. Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am. J. Clin. Nutr. 60:1994;559-566.
31. Piyathilake C.J., Macaluso M., Hine R.J., Vinter D.W., Richards E.W., Krumdieck C.L. Cigarette smoking, intracellular vitamin deficiency, and occurrence of micronuclei in epithelial cells of the buccal mucosa. Cancer Epidemiol. Biomarkers Prev. 4:1995;751-758.
32. Morabia A., Wynder E.L. Dietary habits of smokers, people who never smoked, and exsmokers. Am. J. Clin. Nutr. 52:1990;933-937.
33. Subar A.F., Harlan L.C., Mattson M.E. Food and nutrient intake differences between smokers and non-smokers in the U.S. Am. J. Public Health. 80:1990;323-329.
34. Whichelow M.J., Erzinclioglu S.W., Cox B.D. A comparison of the diets of non-smokers and smokers. Br. J. Addict. 86:1991;71-81.
35. Khaled M.A., Krumdieck C.L. Association of folate molecules as determined by proton NMR Implications on enzyme binding . Biochem. Biophys. Res. Commun. 130:1985;1273-1280.
36. 12 and folate co-enzymes by butyl nitrite as observed by NMR Implications on one-carbon transfer mechanism . Biochem. Biophys. Res. Commun. 135:1986;201-207.
37. Le Marchand L., Yoshizawa C.N., Kolonel L.N., Hankin J.H., Goodman M.T. Vegetable consumption and lung cancer risk A population-based case-control study in Hawaii . J. Natl. Cancer Inst. 81:1989;1158-1164.
38. Bandera E.V., Freudenheim J.L., Marshall J.R., Zielezny M., Priore R.L., Brasure J., Baptiste M., Graham S. Diet and alcohol consumption and lung cancer risk in the New York State Cohort. Cancer Causes Control. 8:1997;828-840.
39. 12. Report of a preliminary randomized, double-blind intervention trial. JAMA. 259:1988;1525-1530.
40. 12 in heavy smokers. Chest. 106:1994;496-499.
41. Van Niekerk W. Cervical cytologic abnormalities caused by folic acid deficiency. Acta Cytol. 10:1966;67-73.
42. Stern E. Steroid contraceptive use and cervical dysplasia Increased risk of progression . Science. 196:1977;1460-1462.
43. Vessey M.P., Lawless M., McPherson Y., Yeates D. Neoplasia of the cervix uteri and contraception A possible adverse effect of the pill . Lancet. 2:1983;930-934.
44. Shojania A.M., Hornady G., Barnes P.H. Oral contraceptives and serum-folate level. Lancet. 1:1968;1376-1377.
45. Paton A. Oral contraceptives and folate deficiency. Lancet. 1:1969;418.
46. Streiff R.R. Folate deficiency and oral contraceptives. JAMA. 214:1970;105-108.
47. Spray G.H. Oral contraceptives and serum folate levels. Lancet. 2:1968;110-111.
48. Whitehead N., Reyner F., Lindenbaum J. Megaloblastic changes in the cervical epithelium. Association with oral contraceptive therapy and reversal with folic acid. JAMA. 226:1973;1421-1424.
49. McPherson R.S. Nutritional factors and the risk of cervical dysplasia. Am. J. Epidemiol. 130:1989;830.
50. Buckley D.I., McPherson R.S., North C.Q., Becker T.M. Dietary micronutrients and cervical dysplasia in Southwestern American Indian women. Nutr. Cancer. 17:1992;179-185.
51. VanEenwyk J., Davis F.G., Colman N. Folate, vitamin C, and cervical intraepithelial neoplasia. Cancer Epidemiol. Biomarkers Prev. 1:1992;119-124.
52. Brock K.E., Berry G., Mock P.A., MacLenna R., Truswell A.S., Brinton L.A. Nutrients in diet and plasma and risk of in situ cervical cancer. J. Natl. Cancer Inst. 80:1988;580-585.
53. Ziegler R.G., Brinton L.A., Hamman R.F., Lehman H.F., Levine R.S., Mallin K., Norman S.A., Rosenthal J.F., Trumble A.C., Hoover R.N. Diet and risk of invasive cervical cancer among white women in the United States. Am. J. Epidemiol. 132:1991;432-445.
54. Verreault R., Chu J., Mandelson M., Shy K. A case-control study of diet and invasive cervical cancer. Int. J. Cancer. 43:1989;1050-1054.
55. Zeigler R.G., Jones C.J., Brinton L.A., Norman S.A., Mallin K., Levine R.S., Lehman H.F., Hamman R.F., Trumble A.C., Rosenthal J.F., Hoover R.N. Diet and risk of in situ cervical cancer among white women in the United States. Cancer Causes Control. 2:1991;17-29.
56. Herrero R., Potischman N., Brinton L.A., Reeves W.C., Brenes M.M., Tenorio F., de Britton R.C., Gaitan E. A case-control study of nutrient status and invasive cervical cancer. I. Dietary indicators. Am. J. Epidemiol. 134:1991;1335-1346.
57. Butterworth C.E. Jr, Hatch K.D., Macaluso M., Cole P., Sauberlich H.E., Soong S.-J., Borst M., Baker V.V. Folate deficiency and cervical dysplasia. JAMA. 267:1992;528-533.
58. Orr J.W. Jr, Wilson K., Bodiford C., Cornwell A., Soong S.J., Honea K.L., Hatch K.D., Shingleton H.M. Nutritional status of patients with untreated cervical cancer. II. Vitamin assessment. Am. J. Obstet. Gynecol. 151:1985;632-635.
59. Potischman N., Brinton L.A., Laiming V.A., Reeves W.C., Brenes M.M., Herroro R., Tenorio F., de Britton R.C., Gaitan E. A case-control study of serum folate levels and invasive cervical cancer. Cancer Res. 51:1991;4785-4789.
60. Schiffman M.H. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J. Natl. Cancer Inst. 84:1992;394-398.
61. Schiffman M.H. New epidemiology of human papillomavirus infection and cervical neoplasia. J. Natl. Cancer Inst. 87:1995;1345-1347.
62. Ran J.Y., Li X.F., Rau H.L., Wang L.Y., Herbert V. Selective folate deficiency in one but no another cell line Despite "normal" red cell folate, folate therapy reduced cervical dysplasia and hyperploidy in women using oral contraceptives . Blood. 76:(suppl 1):1990;114a.
63. Butterworth C.E. Jr, Hatch K.D., Gore H., Mueller H., Krumdieck C.L. Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives. Am. J. Clin. Nutr. 35:1982;73-82.
64. Butterworth C.E. Jr, Hatch K.D., Soong S.-J., Cole P., Tamura T., Sauberlich H.E., Borst M., Macaluso M., Baker V. Oral folic acid supplementation for cervical dysplasia A clinical intervention trial . Am. J. Obstet. Gynecol. 166:1992;803-809.
65. Childers J.M., Chu J., Voigt L.F., Feigl P., Tamimi H.K., Franklin E.W., Alberts D.S., Meyskens F.L. Chemoprevention of cervical cancer with folic acid A phase III Southwest Oncology Group Intergroup study . Cancer Epidemiol. Biomarkers Prev. 4:1995;155-159.
66. Noda K. Cervical intraepithelial neoplasia and microinvasive carcinoma of the cervix. Curr. Top. Pathol. 85:1992;57-80.
67. van Helden P.D., Beyers A.D., Bester A.J., Jaskiewicz K. Esophageal cancer Vitamin and lipotrope deficiencies in an at-risk South African population . Nutr. Cancer. 10:1987;247-255.
68. Jaskiewick K., Marasas W.F.O., Lazarus C., Beyers A.D., van Helden P.D. Association of esophageal cytological abnormalities with vitamin and lipotrope deficiencies in populations at risk for esophageal cancer. Anticancer Res. 8:1988;711-716.
69. Jaskiewicz K. Oesophageal carcinoma Cytopathology and nutritional aspects in aetiology . Anticancer Res. 9:1989;1847-1852.
70. Ran J.Y., Dou P., Wang L.Y., Qin Y., Jin S.Y., Li X.F. Correlation of low serum folate and total B12 with high incidence of esophageal carcinoma in Shanxi, China. Blood. 82:1993;532a.
71. Prasad M.P., Krishna T.P., Pasricha S., Krishnaswamy K., Quereshi M.A. Esophageal cancer and diet - A case-control study. Nutr. Cancer. 18:1992;85-93.
72. Li J.Y., Taylor P.R., Li B., Dawsey S., Wang G.Q., Ershow A.G., Guo W., Liu S.F., Yang C.S., Shen Q., Wang W., Mark S.D., Zou X.-N., Greenwald P., Wu Y.-P., Blot W.J. Nutrition intervention trials in Linxian, China Mutiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia . J. Natl. Cancer Inst. 85:1993;1492-1498.
73. Dawsey S.M., Wang G.Q., Taylor P.R., Li J.Y., Blot W.J., Li B., Lewin K.J., Liu F.S., Weinstein W.M., Wiggett S., Wang H., Mark S.D., Yu Y., Yang C.S. Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach Results from the Dysplasia Trial in Linxian, China . Cancer Epidemiol. Biomarkers Prev. 3:1994;167-172.
74. Mark S.D., Liu S.F., Li J.Y., Gail M.H., Shen Q., Dawsey S.M., Liui F., Taylor P.R., Li B., Blot W.J. The effect of vitamin and mineral supplementation on esophageal cytology Results from the Linxian Dysplasia trial . Int. J. Cancer. 57:1994;162-166.
75. Li J.Y. Epidemiology of esophageal cancer in China. Natl. Cancer Inst. Monogr. 62:1982;113-120.
76. La Vecchia C., Ferraroni M., D'Avanzo B., Decarli A., Franceschi S. Selected micronutrient intake and the risk of gastric cancer. Cancer Epidemiol. Biomarkers Prev. 3:1994;393-398.
77. Nikias G.A., Zhang Z.-F., Sun M., Klimstra D., Kurtz R.C. Smoking, dietary fat, fiber and vitamins influence the progression of chronic gastritis to distal gastric cancer A case-control study . Gastroenterology. 108:1995;A515.
78. Baghurst P.A., McMichael A.J., Slavotinek A.H., Baghurst K.I., Boyle P., Walker A.M. A case-control study of diet and cancer of the pancreas. Am. J. Epidemiol. 134:1991;167-179.
79. 14-aminoazobenezene in vivo. J. Biol. Chem. 196:1952;863-874.
80. Poirier L.A. Hepatocarcinogenesis by diethylnitrosamine in rats fed high dietary levels of lipotropes. J. Natl. Cancer Inst. 54:1975;137-140.
81. Newberne P.M., Rogers A.E. Labile methyl groups and the promotion of cancer. Annu. Rev. Nutr. 6:1986;407-432.
82. Rogers A.E. Chemical carcinogenesis in methyl-deficient rats. J. Nutr. Biochem. 4:1993;666-671.
83. Graham S., Hellmann R., Marshall J., Freudenheim J., Vena J., Swanson M., Zielezny M., Nemoto T., Stubbe N., Raimondo T. Nutritional epidemiology of postmenopausal breast cancer in western New York. Am. J. Epidemiol. 134:1991;552-566.
84. Lewisohn R., Leuchtenberger C., Leuchtenberger R., Keresztesy J.C. The influence of liver L. casei factor on spontaneous breast cancer in mice. Science. 104:1946;436-437.
85. Baggott J.E., Vaughn W.H., Juliana M.M., Eto I., Krumdieck C.L., Grubbs C.J. Effects of folate deficiency and supplementation on methylnitrosourea-induced rat mammary tumors. J. Natl. Cancer Inst. 84:1992;1740-1744.
86. Rosenberg I.H., Mason J.B. Folate dysplasia and cancer. Gastroenterology. 97:1989;502-505.
87. Lashner B.A., Heidenreich P.A., Su G.L., Kane S.V., Hanauer S.B. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study. Gastroenterology. 97:1989;255-259.
88. Isbell G., Levin B. Ulcerative colitis and colon cancer. Gastroenterol. Clin. North Am. 17:1988;773-791.
89. Ekbom A., Helmick C., Zack M., Adami H.-O. Ulcerative colitis and colorectal cancer. A population-based study. N. Engl. J. Med. 323:1990;1228-1233.
90. Elsborg L., Larson L. Folate deficiency in chronic inflammatory bowel disease. Scand. J. Gastroenterol. 14:1979;1019-1024.
91. Swinson C.M., Perry J., Lumb M., Levy A.J. Role of sulphasalazine in the aetiology of folate deficiency in ulcerative colitis. Gut. 22:1981;456-461.
92. Longstreth G.F., Green R. Folate status in patients receiving maintenance doses of sulfasalazine. Arch. Intern. Med. 143:1983;902-904.
93. Franklin J., Rosenberg I. Impaired folic acid absorption in inflammatory bowel disease Effects of salicylazosulfapyradine (Azulfidine) . Gastroenterology. 64:1973;517-525.
94. Selhub J., Dhar G., Rosenberg I. Inhibition of folate enzymes by sulfasalazine. J. Clin. Invest. 61:1978;221-224.
95. Lashner B.A. Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis. J. Cancer Res. Clin. Oncol. 119:1993;549-554.
96. Lashner B.A., Provencher K.S., Seidner D.L., Knesebeck A., Brezezinski A. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology. 112:1997;29-32.
97. Fiedler L., Rubin P., Korelitz B., Sachar D., Present D. Does folate supplementation really protect from dysplasia and cancer in ulcerative colitis? A case control study . Gastroenterology. 104:1993;A700.
98. Pinczowski D., Ekbom A., Baron J., Yuen J., Adami H.-O. Risk factors for colorectal cancer in patients with ulcerative colitis A case-control study . Gastroenterology. 107:1994;117-120.
99. Benito E., Cabeza E., Moreno V., Obrador A., Bosch F.X. Diet and colorectal adenomas A case-control study in Majorca . Int. J. Cancer. 55:1993;213-219.
100. Bird C.L., Swendseid M.E., White J.S., Shikany J.M., Hunt I.F., Frankl H.D., Lee E.R., Longnecker M.P., Haile R.W. Red cell and plasma folate, folate consumption, and the risk of colorectal adenomatous polyps. Cancer Epidemiol. Biomarkers Prev. 4:1995;709-714.
101. Tseng M., Murray S.C., Kupper L.L., Sandler R.S. Micronutrients and the risk of colorectal adenomas. Am. J. Epidemiol. 144:1996;1005-1014.
102. Boutron-Ruault M.-C., Senesse P., Faivre J., Couillault C., Belghiti C. Folate and alcohol intakes Related or independent roles in the adenoma-carcinoma sequence? Nutr. Cancer. 26:1996;337-346.
103. Giovannucci E., Stampfer M.J., Colditz G.A., Rimm E.B., Trichopoulos D., Rosner B.A., Speizer F.E., Willett W.C. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J. Natl. Cancer Inst. 85:1993;875-884.
104. Baron J.A., Sandler R.S., Haile R.W., Mandel J.S., Mott L.A., Greenberg E.R. Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas. J. Natl. Cancer Inst. 90:1998;57-62.
105. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
106. Fearon E.R., Jones P.A. Progressing toward a molecular description of colorectal cancer development. FASEB J. 6:1992;2783-2790.
107. Benito E., Stiggelbout A., Bosch F.X., Obrador A., Kaldor J., Mulet M., Munoz N. Nutritional factors in colorectal cancer risk A case-control study in majorca . Int. J. Cancer. 49:1991;161-167.
108. Freudenheim J.L., Graham S., Marshall J.R., Haughey B.P., Cholewinski S., Wilkinson G. Folate intake and carcinogenesis of the colon and rectum. Int. J. Epidemiol. 20:1991;368-374.
109. Meyer F., White E. Alcohol and nutrients in relation to colon cancer in middle-aged adults. Am. J. Epidemiol. 138:1993;225-236.
110. Ferraroni M., La Vecchia C.L., D'Avanzo B., Negri E., Franceschi S., Decarli A. Selected micronutrient intake and the risk of colorectal cancer. Br. J. Cancer. 70:1994;1150-1155.
111. Glynn S.A., Albanes D., Pietinen P., Brown C.C., Rautalahti M., Tangrea J.A., Gunter E.W., Barrett M.J., Virtamo J., Taylor P.R. Colorectal cancer and folate status A nested case-control study among male smokers . Cancer Epidemiol. Biomarkers Prev. 5:1996;487-494.
112. White E., Shannon J.S., Patterson R.E. Relationship between vitamin and calcium supplement use and colon cancer. Cancer Epidemiol. Biomarkers Prev. 6:1997;769-774.
113. La Vecchia C., Braga C., Negri E., Franceschi S., Russo A., Conti E., Falcini F., Giacosa A., Montella M., Decarli A. Intake of selected micronutrients and risk of colorectal cancer. Int. J. Cancer. 73:1997;525-530.
114. Giovannucci E., Rimm E.B., Ascherio A., Stampfer M.J., Colditz G.A., Willett W.C. Alcohol, low-methionine-low folate diets, and risk of colon cancer in men. J. Natl. Cancer Inst. 87:1995;265-273.
115. Paspatis G.A., Kalafatis E., Oros L., Zourgias V., Koutsioumpa P., Karamanolis D.G. Folate status and adenomatous colonic polyps. A colonoscopically controlled study. Dis. Colon Rectum. 38:1995;64-68.
116. Kim Y.I., Fawaz K., Knox T., Lee Y.M., Norton R., Arora S., Paiva L., Mason J.B. Colonic mucosal concentrations of folate correlate well with blood measurements of folate status in individuals who harbor colorectal polyps. Am. J. Clin. Nutr. 68:1998;866-872.
117. Meenan J., O'Hallinan E., Scott J., Weir D.G. Epithelial cell folate depletion occurs in neoplastic but not adjacent normal colon mucosa. Gastroenterology. 112:1997;1163-1168.
118. Stabler S.P., Marcell P.D., Podell E.R., Allen R.H., Savage D.G., Lindenbaum J. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J. Clin. Invest. 81:1988;466-474.
119. Selhub J., Miller J.W. The pathogenesis of homocysteinemia Interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine . Am. J. Clin. Nutr. 55:1991;131-138.
120. Kim Y.I., Fawaz K., Knox T., Lee Y.M., Norton R., Libby E., Mason J.B. The effect of folate supplementation on systemic and colonic mucosal folate concentrations A randomized, double-blind, placebo-controlled pilot study . Gastroenterology. 112:1997;A592.
121. Cravo M., Fidalgo P., Pereira A.D., Gouveia-Oliveira A., Chaves P., Selhub J., Mason J.B., Mira F.C., Leitao C.N. DNA methylation as an intermediate biomarker in colorectal cancer Modulation by folic acid supplementation . Eur. J. Cancer Prev. 3:1994;473-479.
122. Paspatis G.A., Karamanolis D.G. Folate supplementation and adenomatous colonic polyps. Dis. Colon Rectum. 37:1994;1340-1341.
123. Cravo M.L., Pinto A.G., Chaves P., Cruz J.A., Lage P., Leitao C.N., Costa Mirra F. Effect of folate supplementation on DNA methylation of rectal mucosa in patients with colonic adenomas Correlation with nutrient intake . Clin. Nutr. 17:1998;45-49.
124. Kim Y.I., Baik H.W., Fawaz K., Knox T., Lee Y.M., Norton R., Libby E., Mason J.B. The effect of folate supplementation on molecular markers of colon cancer. Am. J. Gastroenterol. 93:1998;A59.
125. Fenech M., Aitken C., Rinaldi J. Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis. 19:1998;1163-1171.
126. Cravo M., Gloria L., Salazar De Sousa L., Chaves P., Dias Pereira A., Quina M., Nobre Leitao C., Costa Mira F. Folate status, DNA methylation and colon cancer risk in inflammatory bowel disease. Clin. Nutr. 14:1995;50-53.
127. Biasco G., Zannoni U., Paganelli G.M., Santucci R., Gionchetti P., Rivolta G., Miniero R., Pironi L., Calabrese C., Di Febo G., Miglioli M. Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis. Cancer Epidemiol. Biomarkers Prev. 6:1997;469-471.
128. Goelz S.E., Vogelstein B., Hamilton S.R., Feinberg A.P. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science. 228:1985;187-190.
129. Bostick R.M., Fosdick L., Grandits G.A., Lillemoe T.J., Wood J.R., Grambsch P., Louis T.A., Potter J.D. Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients. Cancer Epidemiol. Biomarkers Prev. 6:1997;1011-1019.
130. Cravo M.L., Mason J.B., Dayal Y., Hutchinson M., Smith D., Selhub J., Rosenberg I.H. Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res. 52:1992;5002-5006.
131. Kim Y.-I., Salomon R.N., Graeme-Cook F., Choi S.-W., Smith D.E., Dallal G.E., Mason J.B. Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut. 39:1996;732-740.
132. Shivapurkar N., Tang Z., Frost A., Alabaaster O. Inhibition of progression of aberrant crypt foci and colon tumor development by vitamin E and β-carotene in rats on a high-risk diet. Cancer Lett. 91:1995;125-132.
133. Reddy B.S., Wang C.-X., Aliaga C., Rao C.V., Lubet R.A., Steele V.E., Kelloff G.J. Potential chemopreventive activity of perillyl alcohol and enhancement of experimental colon carcinogenesis by folic acid and genistein. Proc. Am. Assoc. Cancer Res. 37:1996;A1849.
134. Wargovich M.J., Chen C.-D., Jimenez A., Steele V.E., Velasco M., Stephens L.C., Price R., Gray K., Kelloff G.J. Aberrant crypts as a biomarker for colon cancer Evaluation of potential chemopreventive agents in the rat . Cancer Epidemiol. Biomarkers Prev. 5:1996;355-360.
135. Bird R.P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 93:1995;55-71.
136. Kim Y.-I., Mason J.B. Nutritional chemoprevention of gastrointestinal cancers. Gastroenterologist. 4:(suppl 1):1996;S84-S106.
137. Razin A., Szyf M. DNA methylation patterns. Formation and function. Biochim. Biophys. Acta. 782:1984;331-342.
138. Laird P.W., Jaenisch R. The role of DNA methylation in cancer genetics and epigenetics. Annu. Rev. Genet. 30:1996;441-464.
139. Zingg J.-M., Jones P.A. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis. 18:1997;869-882.
140. Razin A., Cedar H. DNA methylation and gene expression. Microbiol. Rev. 55:1991;451-458.
141. Bird A.P. CpG-rich islands and the function of DNA methylation. Nature. 321:1986;209-213.
142. Lews J., Bird A. DNA methylation and chromatin structure. FEBS Lett. 285:1991;155-159.
143. Antequera F., Boyes J., Bird A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell. 62:1990;503-514.
144. Antequera F., Macleod D., Bird A.P. Specific protection of methylated CpGs in mammalian nuclei. Cell. 58:1989;509-517.
145. Wolf S.F., Migeon B.R. Clusters of CpG dinucleotides implicated by nuclease hypersensitivity as control elements of housekeeping genes. Nature. 314:1985;467-469.
146. Keshet I., Leman-Hurwitz J., Cedar H. DNA methylation affects the formation of active chromatin. Cell. 44:1986;535-543.
147. Meehan R.R., Lewis J.D., McKay S., Kleiner E.L., Bird A.P. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell. 58:1989;499-507.
148. Levine L., Cantoni G.L., Razin A. Inhibition of promoter activity by methylation Possible involvement of protein mediators . Proc. Natl. Acad. Sci. USA. 88:1991;6515-6518.
149. Boyes J., Bird A. DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell. 64:1991;1123-1134.
150. Jones P.A., Rideout W.M. III, Shen J.-C., Spruck C.H., Tsai Y.C. Methylation, mutation and cancer. BioEssays. 14:1992;33-36.
151. Li E., Beard C., Jaenisch R. Role for DNA methylation in genomic imprinting. Nature. 366:1993;362-365.
152. Rainier S., Johnson L.A., Dobry C.J., Ping A.J., Grundy P.E., Feinber A.P. Relaxation of imprinted genes in human cancer. Nature. 362:1993;747-749.
153. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. p53 mutations in human cancers. Science. 253:1991;49-53.
154. Greenblatt M.S., Bennett W.P., Hollsteine M., Harris C.C. Mutations in the p53 tumor suppressor gene Clues to cancer etiology and molecular pathogenesis . Cancer Res. 54:1994;4855-4878.
155. Rideout W.M. III, Coetzee G.A., Olumi A.F., Jones P.A. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 gene. Science. 249:1990;1288-1290.
156. Yebra M.J., Bhagwat A.S. A cytosine methyltransferase converts 5-methylcytosine in DNA to thymine. Biochemistry. 34:1995;14752-14757.
157. Shen J.-C., Rideout W.M. III, Jones P.A. High frequency mutagenesis by a DNA methyltransferase. Cell. 71:1992;1073-1080.
158. Yang A.S., Shen J.-C., Zingg J.-M., Mi S., Jones P.A. HhaI and HpaII DNA methyltransferases bind DNA mismatches, methylate uracil and block DNA repair. Nucleic Acids Res. 23:1995;1380-1387.
159. Zapiesek W.F., Cronin G.M., Lyn-Cook B.D., Poirier L.A. The onset of oncogene hypomethylation in the livers of rats fed methyl-deficient, amino acid-defined diets. Carcinogenesis. 13:1992;1869-1872.
160. Dizik M., Christman J.K., Wainfan E. Alterations in expression and methylation of specific genes in livers of rats fed a cancer promoting methyl-deficient diet. Carcinogenesis. 12:1991;1307-1312.
161. Wainfan E., Dizik M., Stender M., Christman J.K. Rapid appearance of hypomethylated DNA in livers of rats fed cancer-promoting methyl-deficient diets. Cancer Res. 49:1989;4094-4097.
162. Wilson M.J., Shivapurkar N., Poirier L.A. Hypomethylation of hepatic nuclear DNA in rats fed with a carcinogenic methyl-deficient diet. Biochem. J. 218:1984;987-990.
163. Locker J., Reddy T.V., Lombardi B. DNA hypomethylation and hepatocarcinogenesis in rats fed a choline-devoid diet. Carcinogenesis. 7:1986;1309-1312.
164. Pogribny I.P., Basnakian A.G., Miller B.J., Lopatina N.G., Poirier L.A., James S.J. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl deficient rats. Cancer Res. 55:1995;1894-1901.
165. Miller J.W., Nadeau M.R., Smith J., Smith D., Selhub J. Folate deficiency induced homocysteinemia in rats Disruption of S-adenosylmethionine′ coordinate regulation of homocysteine metabolism . Biochem. J. 298:1994;415-419.
166. Balaghi M., Horne D.W., Wagner C. Hepatic one-carbon metabolism in early folate deficiency in rats. Biochem. J. 291:1993;145-149.
167. Kim Y.-I., Miller J.W., da Costa K.-A., Nadeau M., Smith D., Selhub J., Zeisel S.H., Mason J.B. Severe folate deficiency causes secondary depletion of choline and phosphocholine in rat liver. J. Nutr. 124:1994;2197-2203.
168. Kim Y.-I., Christman J.K., Fleet J.C., Cravo M.L., Salomon R.N., Smith D., Ordovas J., Selhub J., Mason J.B. Moderate folate deficiency does not cause global hypomethylation of hepatic and colonic DNA or c-myc-specific hypomethylation of colonic DNA in rats. Am. J. Clin. Nutr. 61:1995;1083-1090.
169. Balaghi M., Wagner C. DNA methylation in folate deficiency Use of CpG methylase . Biochem. Biophys. Res. Comm. 193:1993;1184-1190.
170. Kim Y.-I., Pogrbiny I.P., Basnakian A.G., Miller J.W., Selhub J., James S.J., Mason J.B. Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am. J. Clin. Nutr. 65:1997;46-52.
171. Henning S.M., McKee R.W., Swendseid M.E. Hepatic content of S-adenosylmethionine and S-adenosylhomocysteine and glutathione in rats receiving treatments modulating methyl donor availability. J. Nutr. 119:1989;1478-1482.
172. Shivapurkar N., Poirier L.A. Tissue levels of S-adenosylhomocysteine in rats fed methyl-deficient amino acid-defined diets for one to five weeks. Carcinogenesis. 4:1983;1051-1057.
173. Kim Y.-I., Pogribny I.P., Salomon R.N., Choi S.W., Smith D.E., James S.J., Mason J.B. Exon-specific DNA hypomethylation of the p53 gene of rat colon induced by dimethylhydrazine. Modulation by dietary folate. Am. J. Pathol. 149:1996;1129-1137.
174. Hohn T., Corsten S., Rieke S., Muller M., Rothnie H. Methylation of coding region alone inhibits gene expression in plant protoplasts. Proc. Natl. Acad. Sci. USA. 98:1996;8334-8339.
175. Komura J., Okada T., Ono T. Repression of transient expression by DNA methylation in transcribed regions of reporter genes introduced into cultured human cells. Biochim. Biophys. Acta. 1260:1995;73-78.
176. Pogribny I.P., Miller B.J., James S.J. Alterations in hepatic p53 gene methylation patterns during tumor progression with folate/methyl deficient in the rat. Cancer Lett. 115:1997;31-38.
177. Soussi T., de Fromentel C.C., May P. Structural aspects of the p53 gene protein in relation of gene evolution. Oncogene. 5:1990;945-952.
178. de Jong P.J., Grosovsky A.J., Glickman B.W. Spectrum of spontaneous mutation at the APRT locus of Chinese hamster ovary cells An analysis at the DNA sequence level . Proc. Natl. Acad. Sci. USA. 85:1988;3499-3503.
179. Shapiro B.D., Goldblum J.R., Hussain A., Lashner B.A. The role of p53 mutations in colorectal cancer surveillance for ulcerative colitis. Gastroenterology. 112:1997;A1089.
180. Herman J.G., Umar A., Plyak K., Graff J.R., Ahuja N., Issa J.-P.J., Markowitz S., Willson J.K.V., Hamilton S.R., Kinzler K.W., Kane M.F., Kolodner R.D., Vogelstein B., Kunkel T.A., Baylin S.B. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA. 95:1998;6870-6875.
181. Kane M.F., Loda M., Gaida G.M., Lipman J., Mishra R., Goldman H., Jessup J.M., Kolodner R. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57:1997;808-811.
182. Issa J.-P.J., Ottaviano Y.L., Celano P., Hamilton S.R., Davidson N.E., Baylin S.B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genet. 7:1994;536-540.
183. Makos M., Nelkin B.N.D., Lerman M.I., Latif F., Zbar B., Baylin S.B. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc. Natl. Acad. Sci. USA. 89:1992;1929-1933.
184. Laird P.W., Jackson-Grusby L., Fazeli A., Dickinson S.L., Jung W.E., Li E., Weinberg R.A., Jaenisch R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell. 81:1995;197-205.
185. Everson R., Wehr C., Erexson G., MacGregor J. Association of marginal
186. Heath C. Cytogenetic observations in vitamin B12 and folate deficiency. Blood. 27:1966;800-815.
187. Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., Wickramasinghe S.N., Everson R.B., Ames B.N. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage Implications for cancer and neuronal damage . Proc. Natl. Acad. Sci. USA. 94:1997;3290-3295.
188. Das K.C., Mohanty D., Garewal G. Cytogenetics in nutritional megaloblastic anemia. Acta Haematol. 76:1986;146-154.
189. Yunis J.J., Soreng A.L. Constitutive fragile sites and cancer. Science. 226:1984;1199-1204.
190. 10-propargyl-5-8-dideazafolic acid. Cancer Res. 48:1988;2036-2041.
191. Branda R.F., Blickensderfer D.B. Folate deficiency increases genetic damage caused by alkylating agents and gamma-irradiation in Chinese hamster ovary cells. Cancer Res. 53:1993;5401-5408.
192. James S.J., Yin L. Diet-induced DNA damage and altered nucleotide metabolism in lymphocytes from methyl-donor-deficient-rats. Carcinogenesis. 10:1989;1209-1214.
193. Kim Y.-I., Choi S., Mason J.B. Folate deficiency induces DNA strand breaks within mutation-prone exons of the p53 gene in rat colon Implications for colorectal carcinogenesis . Gastroenterology. 110:1996;A542.
194. Laird C., Jaffe E., Karpen G., Lamb M., Nelson R. Fragile sites in human chromosomes as regions of late-replicating DNA. Trends Genet. 3:1987;274-281.
195. Bryant P. Enzymatic restriction of mammalian cell DNA using Pvu II and BamHI Evidence of the double strand break origin of chromosomal aberrations . Int. J. Radiat. Biol. 46:1984;57-65.
196. Bryant P. Use of restriction enzymes to study relationships between DNA double strand breaks and other end-points in mammalian cells. Int. J. Radiat. Biol. 54:1988;869-890.
197. Moynahan M.E., Jasin M. Loss of heterozygosity induced by chromosomal double-strand breaks. Proc. Natl. Acad. Sci. USA. 94:1997;8988-8993.
198. Azajac-Kaye M., Ts'o P.O.P. DNAase I encapsulated in liposomes can induce neoplastic transformation of Syrian hamster embryo cells in culture. Cell. 39:1984;427-437.
199. Bryant P.E., Riches A. Transformation of murine C3H 10T1/2 cells resulting from DNA double strand breaks induced by a restriction endonuclease. Br. J. Cancer. 60:1989;852-854.
200. Borek C., Ong A., Morgan W.F., Cleaver J.E. Morphological transformation of 10T1/2 mouse embryo cells can be initiated by DNA double-strand breaks alone. Mol. Carcinogenesis. 4:1991;243-247.
201. Bennett C.B., Westmoreland T.J., Snipe J.R., Resnick M.A. A double-strand break within a yeast artificial chromosome (YAC) containing human DNA can result in YAC loss, deletion or cell lethality. Mol. Cell Biol. 16:1996;4414-4425.
202. 2 arrest and lethality. Cancer Res. 57:1997;1970-1980.
203. Nelson W., Kastan M. DNA strand breaks The DNA template alterations that trigger p53-dependent DNA damage response pathways . Mol. Cell Biol. 14:1994;1815-1823.
204. James S.J., Basnakian A.G., Miller B.J. In vitro folate deficiency induces deoxynucleotide pool imbalance, apoptosis, and mutagenesis in Chinese hamster ovary cells. Cancer Res. 54:1994;5075-5080.
205. James S.J., Miller B.J., McGarrity L.J., Morris S.M. The effect of folic acid and/or methionine deficiency on deoxyribonucleotide pools and cell cycle distribution in mitogen-stimulated rat lymphocytes. Cell Prolif. 27:1994;395-406.
206. James S.J., Cross D.R., Miller B.J. Alterations in nucleotide pools in rats fed diets deficient in choline, methionine and/or folic acid. Carcinogenesis. 13:1992;2471-2474.
207. Sedwick W., Kutler M., Brown O. Antifolate-induced misincorporation of deoxyuridine monophosphate into DNA Inhibition of high molecular weight DNA synthesis in human lymphoblastoid cells . Proc. Natl. Acad. Sci. USA. 78:1981;917-921.
208. Wickramasinghe S.N., Fida S. Bone marrow cells from vitamin B12- and folate-deficient patients misincorporate uracil into DNA. Blood. 83:1994;1656-1661.
209. Choi S.-W., Kim Y.-I., Weitzel J.N., Mason J.B. Folate depletion impairs DNA excision repair in the colon of the rat. Gut. 43:1998;93-99.
210. Goyette P., Summer J.S., Milos R., Duncan A.M.V., Rosenblatt D.S., Matthews R.G., Rozen R. Human methylenetetrahydrofolate reductase Isolation of CDNA, mapping, and mutation identification . Nat. Genet. 7:1994;195-200.
211. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., van den Heuvel L.P., Rozen R. A candidate genetic risk factor for vascular disease A common mutation in methylenetetrahydrofolate reductase . Nat. Genet. 10:1995;111-113.
212. van der Put N.M., Steegers-Theunissen R.P., Frosst P., Trijbels F.J.M., Eskes T.K., van den Heuvel L.P., Mariman E.C., den Heyer M., Rozen R., Blom H.J. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 346:1995;1070-1071.
213. Jacques P.F., Bostom A.G., Williams R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H., Selhub J., Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 93:1996;7-9.
214. Ma J., Stampfer M.J., Hennekens C.H., Frosst P., Selhub J., Horsford J., Malinow M.R., Willet W.C., Rozen R. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in U.S. physicians. Circulation. 94:1996;2410-2416.
215. Chen J., Giovannucci E., Kelsey K., Rimm E.B., Stampfer M.J., Colditz G.A., Spiegelman D., Willett W.C., Hunter D.J. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 56:1996;4862-4864.
216. Ma J., Stampfer M.J., Giovannucci E., Artigas C., Hunter D.J., Fuchs C., Willett W.C., Selhub J., Hennekens C.H., Rozen R. Methylenetetrahydrofolate reductase polymorphisms, dietary interactions, and risk of colorectal cancer. Cancer Res. 57:1997;1098-1102.
217. Nensey Y.M., Arlow F.L., Majumdar A.P.N. Increased responsiveness of colorectal mucosa to carcinogen stimulation and protective role of folic acid. Dig. Dis. Sci. 40:1995;396-401.
218. Dhur A., Galan P., Hercberg S. Folate status and the immune system. Prog. Food Nutr. Sci. 15:1991;43-60.
219. Trichieri G. Biology of natural killer cells. Adv. Immunol. 47:1989;187-376.
220. Williams E., Gross R., Newberne P. Effect of folate deficiency on the cell-mediated immune response in rats. Nutr. Reports Intern. 12:1975;137-148.
221. Finkelstein J.D., Martin J.J. Methionine metabolism in mammals. Distribution of homocysteine between competing pathways. J. Biol. Chem. 259:1984;9508-9513.
222. Selhub J., Seyoum E., Pomfret E.A., Zeisel S.H. Effects on choline deficiency and methotrexate treatment upon liver folate content and distribution. Cancer Res. 51:1991;16-21.
223. da Costa K., Cochary E., Blusztajn J., Garner S., Zeisel S. Accumulation of 1,2-sn-diacylglycerol with increased membrane-associated protein kinase C may be the mechanism for spontaneous hepatocarcinogenesis in choline deficient rats. J. Biol. Chem. 268:1993;2100-2105.
224. Kopp R., Noelke B., Sauter G., Schildberg F.W., Paumgartner G., Pfeiffer A. Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas. Cancer Res. 51:1991;205-210.
225. Craven P.A., DeRubertis F.R. Alterations in protein kinase C in 1,2-dimethylhydrazine induced colonic carcinogenesis. Cancer Res. 52:1992;2216-2221.
226. Rzengurt E. Early signals in the mitogenic response. Science. 234:1986;161-166.
227. Kaibuchi K., Tsuda T., Kikuchi A., Tanimoto T., Yamashita T., Takai Y. Possible involvement of protein kinase C and calcium ion in growth factor-induced expression of c-myc oncogene in Swiss 3T3 fibroblasts. J. Biol. Chem. 262:1986;1187-1192.
228. Megidish T., Mazurek N. A mutant protein kinase C that can transform fibroblasts. Nature. 343:1989;807-811.
229. Campbell N.R.C. How safe are folic acid supplements? Arch. Intern. Med. 156:1996;1638-1644.
230. Selhub J., Jacques J.F., Wilson P.W.F., Rush D., Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 270:1993;2693-2698.